Device to help remove excess fluid in advanced heart failure
Part of Heart & circulation clinical trials.
This trial tests a device that briefly blocks blood flow in a large vein to help your body remove extra fluid, which may improve symptoms like swelling and shortness of breath. It is for people with advanced heart failure who are already in the hospital and need more help with fluid removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have advanced heart failure (NYHA class III or IV) and are in the hospital with signs of fluid overload, such as swelling in your legs, shortness of breath, or fluid in your lungs.
- You are scheduled to have a right heart catheterization, a procedure that measures pressures in your heart.
- Your kidneys are working well enough (eGFR greater than 30).
- You are not on dialysis and do not have certain heart or blood vessel conditions (like severe valve problems, recent stroke, or blood clots).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the eLym™ device is safe and practical to use in people hospitalized for worsening heart failure with excess fluid. It may help reduce fluid overload while the team checks safety during and after the procedure.
This study tests a device (Reprieve System) to remove extra fluid more safely in heart failure patients while they are hospitalized. It may be a good option if you have fluid buildup and are not too sick from other conditions.
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This trial studies a device (the Nephronyx System) used in the hospital to treat worsening heart failure with fluid buildup, especially when diuretics (water pills) aren’t working well. It aims to check the device’s safety and whether it performs as expected to help patients get better.
Hear when a new Acute Decompensated Heart Failure (ADHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.